Specify a stock or a cryptocurrency in the search bar to get a summary
Cyfuse Biomedical K.K.
4892Cyfuse Biomedical K.K. engages in the development, manufacture, and sale of regenerative medicine products in Japan. It develops cellular products in the field of regenerative therapy; and undertakes contract for cellular products for research and development. The company also offers Bio 3D Printer for use in the regeneration of various tissues and organs, such as cartilage and bones, blood vessels, and nerves; regenova, a bio 3D printer for 3D stacking of cells; and S-PIKE that develops 3D-structures from cells. Cyfuse Biomedical K.K. was incorporated in 2010 and is based in Tokyo, Japan. Address: Sumitomo Fudosan Mita Twin Building, Tokyo, Japan, 108-6301
Analytics
WallStreet Target Price
–P/E ratio
–Dividend Yield
–Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures 4892
Dividend Analytics 4892
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History 4892
Stock Valuation 4892
Financials 4892
Results | 2019 | Dynamics |